Literature DB >> 500119

The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

H A Verbrugh, W C Van Dijk, R Peters, M E Van Der Tol, J Verhoef.   

Abstract

The role of cell-wall peptidoglycan, teichoic acid and protein A in the processes of Staphylococcus aureus complement activation and opsonization was investigated. CH50 consumption studies reveal that, although all cell-surface fractions were capable of activating the classical C pathway, only peptidoglycan consumed C via the alternative pathway. Using a quantitative immunofluorescence assay, peptidoglycan was shown to bind C3 molecules via the classical as well as via the alternative C pathway and in the absence of IgG and IgA class antibodies. C activation via the classical and the alternative pathway could be distinguished by kinetic analysis. By comparing the rates of staphylococcal C consumption, C3 fixation and opsonization it was found that the CH50 consumption assay is a relatively insensitive method and may yield results that do not necessarily reflect the process of bacterial opsonization.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500119      PMCID: PMC1457714     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

Authors:  J I Gallin; R A Clark; M M Frank
Journal:  Clin Immunol Immunopathol       Date:  1975-01

2.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

Authors:  J Verhoef; P Peterson; Y Kim; L D Sabath; P G Quie
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

5.  Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.

Authors:  H A Verbrugh; W C Van Dijk; R Peters; M E Van Der Tol; P K Peterson; J Verhoef
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

6.  Quantitative fluorescent immunoassay of antibodies to, and surface antigens of, Actinomyces viscosus.

Authors:  T P Gillis; J J Thompson
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

7.  The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; S D Douglas; P G Quie; J Verhoef
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

8.  Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.

Authors:  H A Verbrugh; R Peters; P K Peterson; J Verhoef
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

9.  Activation of complement by cell surface components of Staphylococcus aureus.

Authors:  B J Wilkinson; Y Kim; P K Peterson; P G Quie; A F Michael
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

10.  The opsonic fragment of the third component of human complement (C3).

Authors:  T P Stossel; R J Field; J D Gitlin; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

View more
  20 in total

1.  Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Authors:  Anne-Catherine Raby; Chantal S Colmont; Ann Kift-Morgan; Jörg Köhl; Matthias Eberl; Donald Fraser; Nicholas Topley; Mario O Labéta
Journal:  J Am Soc Nephrol       Date:  2016-07-18       Impact factor: 10.121

2.  Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process.

Authors:  E M Veringa; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

3.  Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum.

Authors:  A Pascual; A Fleer; N A Westerdaal; M Berghuis; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.

Authors:  M E Agüero; L Aron; A G DeLuca; K N Timmis; F C Cabello
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

5.  In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.

Authors:  J D Lambris; J B Allen; J H Schwab
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Staphylococcus aureus coagulases are exploitable yet stable public goods in clinically relevant conditions.

Authors:  Urvish Trivedi; Jonas S Madsen; Jake Everett; Cody Fell; Jakob Russel; Jakob Haaber; Heidi A Crosby; Alexander R Horswill; Mette Burmølle; Kendra P Rumbaugh; Søren J Sørensen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

7.  Group A streptococcal peptidoglycan-polysaccharide inhibits phagocytic activity of human polymorphonuclear leukocytes.

Authors:  P A Leong; M S Cohen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

8.  Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry.

Authors:  Hui Chen; Michael C Schuster; Georgia Sfyroera; Brian V Geisbrecht; John D Lambris
Journal:  J Am Soc Mass Spectrom       Date:  2008-01       Impact factor: 3.109

9.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

10.  Complement consumption gonococcal peptidoglycan.

Authors:  B H Petersen; R S Rosenthal
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.